Articles

Peptides

AI & Peptide Science: What's Real, What's Hype, and What's Coming

Artificial intelligence has made genuine, peer-reviewed breakthroughs in protein structure prediction, de novo peptide design, and drug discovery pipelines. It has also become a marketing term used to sell unvalidated supplement stacks. This evidence-first guide separates the two — covering AlphaFold, RFdiffusion, personalized medicine research, manufacturing QC, and what all of it means for you right now.

WellSourced Editorial· May 10, 2026· 16 min read

peptides

Best Peptides for Women 50+: Menopause, Cognitive Health & Longevity

The post-menopausal body is not broken. It is operating in a different hormonal environment — one that changes the risk-benefit calculus for every intervention, peptides included. This is the guide that takes that seriously.

WellSourced Editorial· May 10, 2026· 22 min read

Peptides

Best Peptides for Men in Their 40s (2026 Guide)

Your 40s are the decade where the numbers start to move. Testosterone dips ~1% per year, GH pulses get shorter, joints accumulate mileage, and recovery takes longer than it used to. Peptides won't stop the clock — but the right ones, stacked intelligently, can meaningfully change the trajectory. Here's what the evidence says.

WellSourced Editorial· May 10, 2026· 18 min read

peptides

Best Peptides for Women in Their 40s — Perimenopause, Longevity & Joint Health

The 40s are a hormonal inflection point for women — declining estrogen, shifting GH secretion, accelerating collagen loss, rising inflammation. Here's what the evidence actually says about peptides at this life stage.

WellSourced Editorial· May 10, 2026· 18 min read

peptides

Best Peptides for Women in Their 20s–30s: Recovery, Performance & Body Composition

Most peptide content is written for men or defaults to anti-aging framing aimed at women over 50. This guide is for athletic women in their 20s and 30s — the ones training hard, managing recovery, and making informed decisions about research compounds. Evidence-first, no patronizing, no fear-mongering.

WellSourced Editorial· May 10, 2026· 18 min read

peptides

Best Peptides for Men 50+: Longevity, Cognitive Health & Recovery

Men over 50 are at a fundamentally different physiological starting point than they were at 30. Testosterone has declined 30–40%. Growth hormone output is at roughly 20% of peak. The peptides worth considering at this stage — and the cautions that come with them — are different from what a 35-year-old athlete needs. This is the honest guide.

WellSourced Editorial· May 10, 2026· 20 min read

peptides

Best Peptides for Men in Their 20s–30s

A performance-focused guide to peptides for men in their 20s and 30s — BPC-157, TB-500, CJC-1295/Ipamorelin, MK-677, and GHK-Cu ranked by evidence, with dosing, safety, cost, and hormonal context.

WellSourced Editorial· May 10, 2026· 18 min read

peptides

HBOT for Peptide Users: The Recovery Stack

Hyperbaric oxygen therapy and peptides share overlapping mechanisms — angiogenesis, collagen synthesis, tissue repair. Here's how to actually stack them, and what the evidence actually says.

WellSourced Editorial· May 10, 2026· 16 min read

Peptides

FDA-Approved Peptides & the Compounding Pharmacy Pipeline (Part 2)

Part 2 of our physician-led peptide series covers the full regulatory picture: FDA-approved therapies (semaglutide, tirzepatide, tesamorelin), how compounding pharmacies legally provide peptides, the 503A vs. 503B distinction, contamination realities, and what the April 23 reclassification and July PCAC hearing mean for peptide access in 2026.

WellSourced Editorial· May 10, 2026· 15 min read

peptides

BPC-157 Protocol Guide: Dosing, Reconstitution & Injection Sites

Everything you need to actually use BPC-157: how to reconstitute it, calculate your dose, choose injection sites, cycle it properly, and stay safe doing it.

WellSourced Editorial· May 10, 2026· 14 min read

peptides

Peptide Supplier Buyer's Guide 2026: How to Find Trusted Sources After the Peptide Sciences Shutdown

Peptide Sciences shut down March 6, 2026. Gray-market contamination rates jumped overnight. This evidence-based guide shows how to verify any peptide supplier using independent CoA testing standards — and explains what the July 23–24 FDA PCAC hearing means for your access.

WellSourced Editorial· May 8, 2026· 17 min read

peptides

The 2026 Peptide Tier List: S/A/B/C Rankings

An opinionated ranking of the most-talked-about peptides in 2026, organized by tier (S/A/B/C) based on evidence quality, safety, regulatory accessibility, and real-world utility.

WellSourced Editorial· May 8, 2026· 18 min read

peptides

Bioregulators vs. Peptides — What's the Difference?

Epithalon, Thymalin, Vilon, Vesugen — these aren't standard peptides. They're bioregulators: 2–4 amino acid sequences that appear to interact directly with gene promoters and histones to regulate tissue-specific gene expression. Here's what that means, what the evidence actually shows, and why the distinction matters.

WellSourced Editorial· May 6, 2026· 16 min read

peptides

FDA PCAC July 2026 Hearing: What the Panel Will Decide About BPC-157, Semax, Epitalon, and Four More Peptides

On July 23-24, 2026, the FDA's Pharmacy Compounding Advisory Committee meets to decide the fate of BPC-157, Semax, Epitalon, TB-500, MOTS-C, KPV, and Emideltide. Here is what the committee actually does, what it will evaluate, and what a favorable — or unfavorable — outcome means for you.

WellSourced Editorial· May 6, 2026· 16 min read

peptides

Peptide Delivery Methods: How Peptides Get Into Your System

Not all peptide delivery routes are equal — and the difference between oral and injectable BPC-157, or why GHK-Cu works in a cream but CJC-1295 doesn't, comes down to molecular weight, enzymatic stability, and biology. A complete, evidence-graded guide to every delivery method.

WellSourced Editorial· May 4, 2026· 18 min read

peptides

How to Reconstitute Peptides — Step-by-Step Guide

You've got the vial. You've got the powder. Now what? This is the practical, no-nonsense guide to reconstituting peptides — from what you need to how many units to draw.

WellSourced Editorial· April 25, 2026· 10 min read

peptides

BPC-157: Complete Guide to Benefits, Dosing & Protocols [2026]

BPC-157 is a 15-amino acid synthetic peptide with over 700 peer-reviewed studies behind it. It stimulates angiogenesis, collagen synthesis, and anti-inflammatory signaling to accelerate healing of tendons, ligaments, joints, and the gut lining. This guide covers everything from mechanism to dosing to the 2026 regulatory update.

WellSourced Editorial· April 25, 2026· 18 min read

peptides

Are Peptides Legal Again? What the FDA Reclassification Actually Means

On April 15, 2026, the FDA removed BPC-157, TB-500, and 10 other peptides from its banned Category 2 list. But "removed from the ban list" and "legal to buy" aren't the same thing. Here's exactly where things stand — and what comes next.

WellSourced Editorial· April 23, 2026· 14 min read

peptides

Best Peptide Suppliers 2026 — Trusted Sources Ranked

Peptide Sciences closed. Amino Asylum was raided. Here's who's left standing — and who's actually worth your money in 2026.

WellSourced Editorial· April 22, 2026· 12 min read

Peptides

Semaglutide → Tirzepatide → Retatrutide: The Weight Loss Drug Evolution Explained

Three drugs. Three generations. A 14-percentage-point gap in weight loss between the first and third. Here is what changed at the molecular level, what Phase 3 shows — and what it means in practice.

WellSourced Editorial· April 15, 2026· 24 min read

Peptides

Peptides for Brain Fog: Why It's Not a Focus Problem, It's an Inflammation Problem

Brain fog isn't a focus problem. It's inflammation, gut-brain axis dysfunction, and mitochondrial depletion. This guide covers the four root causes, peptide solutions for each (Semax, Selank, BPC-157, MOTS-c), and a practical protocol that actually addresses the mechanism — not just the symptom.

WellSourced Editorial· April 15, 2026· 24 min read

peptides

PT-141 (Bremelanotide/Vyleesi): The FDA-Approved Libido Peptide — What the Science Says

PT-141 (bremelanotide/Vyleesi) is the FDA-approved peptide for HSDD in premenopausal women. Unlike PDE5 inhibitors, it works centrally via melanocortin receptors in the brain — affecting desire and arousal at the source. Here's the complete picture: clinical data, mechanism, dosing, side effects, and honest assessment.

WellSourced Editorial· April 15, 2026· 12 min read

peptides

PT-141 (Bremelanotide): The FDA-Approved Peptide for Sexual Health

PT-141 (bremelanotide) is FDA-approved as Vyleesi for HSDD in premenopausal women. It works via melanocortin receptors in the brain — not blood vessels like PDE5 inhibitors. The complete guide covers mechanism, clinical data, dosing, and side effects.

WellSourced Editorial· April 15, 2026· 8 min read

Peptides

The GLP-1 Side Effect Survival Guide: Peptides That Help

GLP-1 drugs work. The side effects are real too. Here is what is actually known about managing nausea, muscle loss, Ozempic face, gastroparesis, and gallbladder risk — including which peptide protocols have evidence behind them and which are community-driven.

WellSourced Editorial· April 15, 2026· 18 min read

peptides

SS-31 (Elamipretide): The Mitochondrial Inner Membrane Peptide

SS-31 (Elamipretide) is a precision mitochondrial peptide that targets cardiolipin on the inner mitochondrial membrane. Phase II human trials in heart failure and Barth syndrome have earned it FDA Breakthrough Therapy Designation — making it the most clinically advanced mitochondrial-targeting compound in development.

WellSourced Editorial· April 15, 2026· 18 min read

peptides

The GLP-1 Side Effect Survival Guide — What Peptides Can and Cannot Do

GLP-1 medications like semaglutide and tirzepatide are rewriting obesity medicine. The side effects — nausea, muscle loss, gastroparesis, skin changes — are also very real. This is what the evidence says about peptide support strategies.

WellSourced Editorial· April 15, 2026· 22 min read

Peptides

Peptides for Menopause: The 2026 Guide Nobody's Writing Honestly

Menopause is one of the most consequential hormonal transitions a person can experience — and peptide science is finally catching up. This is the comprehensive, no-hype breakdown of what peptides can and cannot do during perimenopause and menopause.

WellSourced Editorial· April 15, 2026· 24 min read

peptides

Semax vs Selank: The Nootropic Peptides Your Psychiatrist Doesn't Know About

Semax boosts focus and BDNF via ACTH-like mechanisms. Selank quiets anxiety without sedation or dependence via selective GABA-A modulation. Both emerged from Soviet-era neuroscience and are approved drugs in Russia. Here's the full honest picture — and how they compare to modafinil, SSRIs, and benzos.

WellSourced Editorial· April 15, 2026· 18 min read

peptides

Peptide Stacking 101: The Wolverine Stack, Longevity Protocol & Cognitive Stack Explained

Peptide stacking is the biggest trend in biohacking right now — covered by National Geographic, Harper's Bazaar, and Goop. Here's the unfiltered breakdown of the three stacks dominating the conversation, and what the evidence actually says about each one.

WellSourced Editorial· April 15, 2026· 20 min read

Peptides

Thymosin Alpha-1: The Immune Peptide That Actually Works

While the US debates it, 35+ countries prescribe it. Thymosin Alpha-1 (Tα1) is backed by more human clinical trial data than almost any other peptide in the wellness space. Here is what the evidence actually shows.

WellSourced Editorial· April 15, 2026· 18 min read

Peptides

Semax: The Complete Guide — Mechanism, Evidence, Dosing, and the NA-Semax-A Variant

Semax is a synthetic ACTH fragment developed by the Russian Academy of Sciences with decades of clinical use for cognitive disorders and stroke recovery. This guide covers the full mechanism, evidence base, NA-Semax-A variant, and dosing protocols.

WellSourced Editorial· April 15, 2026· 18 min read

Peptides

Is Peptide Stacking Safe? What Goop Won't Tell You

Stacking peptides sounds like a productivity hack for your biology. But between the influencer endorsements and the Goop glossaries, the actual risk picture is murky. Here's what the evidence — and the doctors — actually say.

WellSourced Editorial· April 15, 2026· 18 min read

Peptides

MOTS-c — Exercise in a Molecule?

A 16-amino acid peptide encoded in your mitochondria activates the same metabolic master switch as a hard workout. WADA banned it in 2024. The biohacking community is self-experimenting anyway. Here's what the science actually says.

WellSourced Editorial· April 15, 2026· 22 min read

peptides

SS-31 (Elamipretide) — Why This Mitochondrial Peptide Matters for Everyone

In September 2025, the FDA approved the first mitochondria-targeted drug ever — elamipretide, originally known as SS-31. What started as a treatment for a rare genetic disorder is now one of the most talked-about longevity compounds in biohacking circles. Here's everything the science actually shows.

WellSourced Editorial· April 15, 2026· 20 min read

peptides

AOD-9604: The HGH Fragment That Promised Effortless Fat Loss — and What the Trials Actually Showed

AOD-9604 is the lipolytic fragment of human growth hormone — engineered to burn fat without raising IGF-1 or blood glucose. Phase II trials were promising. Phase III failed. Here is what that means for anyone considering it.

WellSourced Editorial· April 15, 2026· 18 min read

peptides

The Gut-Peptide Connection: BPC-157 + KPV for Digestive Healing

BPC-157 repairs gut tissue. KPV quiets the inflammation. Together, they target the two root mechanisms behind most chronic GI conditions — and the research is more compelling than you might expect.

WellSourced Editorial· April 15, 2026· 18 min read

Peptides

GLP-1s, Ozempic & the Culture War — What the Science Says Beyond the Headlines

Between red carpet speculation and insurance battles, the actual science of GLP-1 drugs keeps getting lost. This is the comprehensive, no-moralizing breakdown of what semaglutide and tirzepatide actually do — and what they don't.

WellSourced Editorial· April 15, 2026· 26 min read